Home/Insurance & Coverage/Cost-Effectiveness Analysis of CGM
Back to Insurance & Coverage

Cost-Effectiveness Analysis of CGM

Understanding the long-term cost-effectiveness of CGM technology compared to traditional glucose monitoring methods.

Cost-Effectiveness Analysis of CGM

Beyond Upfront Costs

While CGMs have higher initial costs than traditional fingerstick testing, comprehensive cost-effectiveness analysis considers long-term outcomes.

Direct Cost Comparison

CGM Costs

  • Monthly sensor/transmitter supplies: $75-$400
  • Initial receiver (if needed): $200-$300
  • Smartphone app: Usually free

Traditional Testing Costs

  • Test strips: $0.50-$1.50 each
  • Lancets: Minimal cost
  • Glucose meter: Often free with strip purchase

Hidden Cost Considerations

CGM Benefits

  • Reduced hypoglycemic events → fewer ER visits
  • Improved A1C → lower complication costs
  • Earlier detection of trends → preventive action
  • Reduced fingerstick supplies

Long-term Savings

Studies suggest CGM use can reduce:

  • Hospitalizations
  • Diabetes-related complications
  • Work absenteeism

Insurance Perspective

Insurers increasingly recognize that the upfront investment in CGM technology can result in:

  • Lower total cost of care
  • Reduced emergency utilization
  • Better chronic disease management outcomes